Eric M. Horwitz spends much of his time researching Prostate cancer, Radiation therapy, Prostate, Internal medicine and Prostate-specific antigen. His work carried out in the field of Prostate cancer brings together such families of science as Brachytherapy, Surgery, Nuclear medicine and Urology. Eric M. Horwitz interconnects Stage and Clinical trial in the investigation of issues within Radiation therapy.
Eric M. Horwitz usually deals with Prostate and limits it to topics linked to Carcinoma and Tumor Oxygenation. Many of his studies on Internal medicine apply to Oncology as well. His research integrates issues of Predictive value of tests and Proportional hazards model in his study of Prostate-specific antigen.
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Radiation therapy and Prostate. The concepts of his Prostate cancer study are interwoven with issues in Surgery, Brachytherapy and Urology. His work in the fields of Internal medicine, such as Androgen deprivation therapy, Disease, Biochemical failure and Androgen, overlaps with other areas such as In patient.
His Oncology study integrates concerns from other disciplines, such as Androgen suppression, Randomized controlled trial, External beam radiation and Clinical trial. Eric M. Horwitz has included themes like Multivariate analysis, Gynecology, Proportional hazards model and Nuclear medicine in his Radiation therapy study. His studies deal with areas such as Radiation treatment planning, Biopsy, Radiology, Carcinoma and Perineural invasion as well as Prostate.
Eric M. Horwitz mainly focuses on Prostate cancer, Internal medicine, Oncology, Radiation therapy and Brachytherapy. His Prostate cancer research is multidisciplinary, incorporating perspectives in Prostate, Radiology and Urology. His study looks at the relationship between Urology and topics such as Bladder cancer, which overlap with Cisplatin.
His Oncology study also includes fields such as
The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Radiation therapy and Cancer. Eric M. Horwitz combines subjects such as Quality of life, Proportional hazards model, Brachytherapy and Urology with his study of Prostate cancer. The study incorporates disciplines such as Dose fractionation, Prostate and Toxicity in addition to Urology.
His Internal medicine research is mostly focused on the topic Disease. His work carried out in the field of Oncology brings together such families of science as Interquartile range and Randomized controlled trial. The Radiation therapy study combines topics in areas such as Survival rate and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prostate cancer. Clinical practice guidelines in oncology.
James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby.
Journal of The National Comprehensive Cancer Network (2010)
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico.
Journal of The National Comprehensive Cancer Network (2019)
Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02
Gerald E. Hanks;Thomas F. Pajak;Arthur Porter;David Grignon.
Journal of Clinical Oncology (2003)
Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
Eric M. Horwitz;Kyounghwa Bae;Gerald E. Hanks;Arthur Porter.
Journal of Clinical Oncology (2008)
Prostate Cancer, Version 1.2016
James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico.
Journal of The National Comprehensive Cancer Network (2016)
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
Michael J. Zelefsky;Deborah A. Kuban;Larry B. Levy;Louis Potters.
International Journal of Radiation Oncology Biology Physics (2007)
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley.
The New England Journal of Medicine (2012)
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
Brian J. Davis;Eric M. Horwitz;W. Robert Lee;Juanita M. Crook.
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.
Alan Pollack;Gail Walker;Eric M. Horwitz;Robert Price.
Journal of Clinical Oncology (2013)
Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology
James L. Mohler;Philip W. Kantoff;Andrew J. Armstrong;Robert R. Bahnson.
Journal of The National Comprehensive Cancer Network (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: